|
Real-time Estimate
Cboe BZX
11:31:12 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 38.60 USD | -2.69% |
|
-10.44% | +25.99% |
| 08-05 | Rapport Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-28 | William Blair Initiates Rapport Therapeutics at Outperform | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.9B | - | - | - | - | - |
| 46.68B | |||||
| 44.42B | |||||
| 41.32B | - | - | - | - | - |
| 41.58B | |||||
| 30.14B |
Select your edition
All financial news and data tailored to specific country editions
